MYB is involved in the DNA damage response in human ER+ breast cancer cells

被引:0
|
作者
Yang, R-M
Dray, E.
Mitra, P.
Gonda, T. J.
机构
[1] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[2] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia
[3] Translat Res Inst Australia, Brisbane, Qld, Australia
关键词
D O I
10.1158/1538-7445.SABCS15-P4-07-09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-07-09
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells
    Sameni, Safoura
    Hande, M. Prakash
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 82 : 256 - 268
  • [22] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    CANCER RESEARCH, 2023, 83 (05)
  • [23] Second Oral SERD Shines in ER+ Breast Cancer
    Pob, Alissa
    CANCER DISCOVERY, 2023, 13 (03) : 522
  • [24] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [25] MYB suppresses differentiation and apoptosis of human breast cancer cells
    Drabsch, Yvette
    Ramsay, Robert G.
    Gonda, Thomas J.
    BREAST CANCER RESEARCH, 2010, 12 (04):
  • [26] PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells
    Miranda E. Clements
    Rachelle W. Johnson
    Oncogene, 2020, 39 : 1318 - 1334
  • [27] TRIM29 Functions as a Tumor Suppressor in Nontumorigenic Breast Cells and Invasive ER+ Breast Cancer
    Liu, Jin
    Welm, Bryan
    Boucher, Ken M.
    Ebbert, Mark T. W.
    Bernard, Philip S.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (02): : 839 - 847
  • [28] Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
    Adrian Britschgi
    Joana Pinto Couto
    Mohamed Bentires-Alj
    Nature, 2021, 591 : E11 - E12
  • [29] Reply to: Hippo signalling maintains ER expression and ER+ breast cancer growth
    Britschgi, Adrian
    Couto, Joana Pinto
    Bentires-Alj, Mohamed
    NATURE, 2021, 591 (7848) : E11 - E12
  • [30] MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
    Michael J. G. Milevskiy
    Udai Gujral
    Carolina Del Lama Marques
    Andrew Stone
    Korinne Northwood
    Lez J. Burke
    Julia M. W. Gee
    Kenneth Nephew
    Susan Clark
    Melissa A. Brown
    British Journal of Cancer, 2019, 120 : 621 - 632